• Initiator Pharma appointed Annette Säfholm as chief operating business officer, adding her to the management team.
• She will support the CEO on business development, partnering, strategic discussions, operational execution.
• Säfholm previously served as CEO of Gedea Biotech, leading it through clinical development, EU MDR approval, commercial readiness.
• The appointment comes as the company advances a Phase IIa pudafensine study in vulvodynia, targeting topline data by end-2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Initiator Pharma A/S published the original content used to generate this news brief on September 14, 2026, and is solely responsible for the information contained therein.